Hiromi Aono

Hiromi Aono

Auto-generated profile, based on publicly available information

Hiromi Aono

Department of Respiratory Medicine, Tokyo Metropolitan Police Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
PDF file
KYKazuhiko Yamada
Kazuhiko Yamada
HAHiromi Aono
Hiromi Aono
YHYukio Hosomi
Yukio Hosomi
HOHiroaki Okamoto
Hiroaki Okamoto
TKTerufumi Kato
Terufumi Kato
KWKoshiro Watanabe
Koshiro Watanabe

18 December 2023 in Vaccine
Verified
Journal Article
Open access
TATakeshi Arashiro
Takeshi Arashiro
MMMaki Miwa
Maki Miwa
HNHidenori Nakagawa
Hidenori Nakagawa
JTJunpei Takamatsu
Junpei Takamatsu
KOKunihiro Oba
Kunihiro Oba
MSMotoi Suzuki
Motoi Suzuki
Since the SARS-CoV-2 Omicron variant became dominant, assessing COVID-19 vaccine effectiveness (VE) against severe disease using hospitalization as an outcome became more challenging due to incidental infections via admission screening and variable admission criteria, resulting in a wide range of estimates. To address this, the World Health Organization (WHO) guidance recommends the use of outcomes that are more specific to severe pneumonia such as oxygen use and mechanical ventilation. A case-control study was conducted in 24 hospitals in Japan for the Delta-dominant period (August-November 2021; "Delta") and early Omicron (BA.1/BA.2)-dominant period (January-June 2022; "Omicron"). Detailed chart review/interviews were conducted in January-May 2023. VE was measured using various outcomes including disease requiring oxygen therapy, disease requiring invasive mechanical ventilation (IMV), death, outcome restricting to "true" severe COVID-19 (where oxygen requirement is due to COVID-19 rather than another condition(s)), and progression from oxygen use to IMV or death among COVID-19 patients. The analysis included 2125 individuals with respiratory failure (1608 cases [75.7%]; 99.2% of vaccinees received mRNA vaccines). During Delta, 2 doses provided high protection for up to 6 months (oxygen requirement: 95.2% [95% CI:88.7-98.0%] [restricted to "true" severe COVID-19: 95.5% {89.3-98.1%}]; IMV: 99.6% [97.3-99.9%]; fatal: 98.6% [92.3-99.7%]). During Omicron, 3 doses provided high protection for up to 6 months (oxygen requirement: 85.5% [68.8-93.3%] ["true" severe COVID-19: 88.1% {73.6-94.7%}]; IMV: 97.9% [85.9-99.7%]; fatal: 99.6% [95.2-99.97]). There was a trend towards higher VE for more severe and specific outcomes. Multiple outcomes pointed towards high protection of 2 doses during Delta and 3 doses during Omicron. These results demonstrate the importance of using severe and specific outcomes to accurately measure VE against severe COVID-19, as recommended in WHO guidance in settings of intense transmission as seen during Omicron.

12 October 2023 in Respirology Case Reports
Verified
Journal Article
Open access
TKTomoko Kuroda
Tomoko Kuroda
KIKazushige Ichikawa
Kazushige Ichikawa
SHSatoshi Hinata
Satoshi Hinata
KCKaoru Chiba
Kaoru Chiba
KOKen Okabayashi
Ken Okabayashi
KMKazuyoshi Marumo
Kazuyoshi Marumo
We share our experiences of instructing three patients with severe upper limb dysfunction on how to self‐adjust CPAP/NPPV masks. In Case 1, we simplified the procedure by suturing a part of the headband as the left forearm was amputated. In Case 2, the patient had congenitally short limbs with short stature; thus, we provided an additional belt to the headband to maintain the headband's configuration while wearing the mask. In Case 3, the patient had left hemiplegia due to stroke and, repetitive coaching was conducted during the recovery phase rehabilitation program. Difficulties with self‐adjusting NPPV/CPAP masks can occur whenever there is limited hand mobility above the head, including upper limb dysfunction. Simplifying procedures and providing sufficient time for instruction could help achieve independence. There have been no previous reports describing similar training details. We believe that sharing this knowledge will be helpful to both patients and healthcare professionals.